| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,593 |
5,348 |
$1.05M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,712 |
8,465 |
$720K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,420 |
2,287 |
$668K |
| 80053 |
Comprehensive metabolic panel |
9,019 |
7,933 |
$633K |
| X4011 |
State-specific procedure code |
1,212 |
1,142 |
$616K |
| Y7506 |
|
2,755 |
2,420 |
$593K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,157 |
1,975 |
$592K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
992 |
665 |
$261K |
| 81003 |
|
4,198 |
3,910 |
$224K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,375 |
2,228 |
$211K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,695 |
2,520 |
$150K |
| G0378 |
Hospital observation service, per hour |
283 |
204 |
$142K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
463 |
450 |
$116K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
787 |
740 |
$114K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
800 |
779 |
$87K |
| 36415 |
Collection of venous blood by venipuncture |
3,021 |
2,530 |
$60K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,533 |
1,318 |
$60K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
976 |
883 |
$52K |
| 87070 |
|
196 |
192 |
$49K |
| 87631 |
|
522 |
497 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
551 |
505 |
$25K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,177 |
902 |
$22K |
| X4003 |
|
211 |
188 |
$15K |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
465 |
440 |
$9K |
| Y7507 |
|
56 |
52 |
$9K |
| 11721 |
|
1,098 |
877 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
239 |
176 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
116 |
110 |
$7K |
| 81025 |
|
90 |
81 |
$6K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13 |
12 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
86 |
78 |
$5K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
55 |
49 |
$5K |
| 99222 |
Initial hospital care, per day, moderate complexity |
63 |
60 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
100 |
50 |
$5K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
104 |
92 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
26 |
24 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
72 |
63 |
$3K |
| 84484 |
|
369 |
284 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18 |
12 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
55 |
53 |
$2K |
| 80306 |
|
26 |
26 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
12 |
12 |
$2K |
| J3490 |
Unclassified drugs |
98 |
76 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
94 |
36 |
$1K |
| Q3014 |
Telehealth originating site facility fee |
113 |
93 |
$1K |
| 83690 |
|
197 |
179 |
$941.86 |
| 85652 |
|
136 |
127 |
$665.24 |
| 85610 |
|
226 |
204 |
$658.97 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
49 |
25 |
$585.16 |
| 86140 |
|
82 |
75 |
$420.12 |
| 83880 |
|
12 |
12 |
$296.76 |
| 82550 |
|
44 |
39 |
$186.38 |
| 83735 |
|
32 |
25 |
$149.88 |
| 85379 |
|
25 |
24 |
$128.20 |
| 85730 |
|
15 |
14 |
$77.38 |
| G0127 |
Trimming of dystrophic nails, any number |
14 |
14 |
$35.96 |